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Abstract
Epithelial to mesenchymal transition (EMT) is a critical event in cancer progression and is closely linked to the breast
epithelial cancer stem cell phenotype. Given the close interaction between the vascular endothelium and cancer cells,
especially at the invasive front, we asked whether endothelial cells might play a role in EMT. Using a 3D culture model we
demonstrate that endothelial cells are potent inducers of EMT in D492 an immortalized breast epithelial cell line with stem
cell properties. Endothelial induced mesenchymal-like cells (D492M) derived from D492, show reduced expression of
keratins, a switch from E-Cadherin (E-Cad) to N-Cadherin (N-Cad) and enhanced migration. Acquisition of cancer stem cell
associated characteristics like increased CD44high/CD24low ratio, resistance to apoptosis and anchorage independent growth
was also seen in D492M cells. Endothelial induced EMT in D492 was partially blocked by inhibition of HGF signaling. Basal-
like breast cancer, a vascular rich cancer with stem cell properties and adverse prognosis has been linked with EMT. We
immunostained several basal-like breast cancer samples for endothelial and EMT markers. Cancer cells close to the vascular
rich areas show no or decreased expression of E-Cad and increased N-Cad expression suggesting EMT. Collectively, we have
shown in a 3D culture model that endothelial cells are potent inducers of EMT in breast epithelial cells with stem cell
properties. Furthermore, we demonstrate that basal-like breast cancer contains cells with an EMT phenotype, most
prominently close to vascular rich areas of these tumors. We conclude that endothelial cells are potent inducers of EMT and
may play a role in progression of basal-like breast cancer.
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Introduction
Epithelial to mesenchymal transition (EMT) is associated with
increased aggressiveness and adverse prognosis in carcinomas
[1,2]. This conversion of cancer cells towards a more mesenchy-
mal phenotype involves loss or lowered expression of epithelial
markers (e.g. E-Cad and keratins), increased expression of
mesenchymal markers (e.g. N-Cad, vimentin, fibronectin), in-
creased mobility and an invasive phenotype [3,4,5]. EMT in
breast cancer is tightly linked to the triple negative (ER-, PR- and
ErbB2-) basal-like breast cancer subgroup and cancer stem cells
[6,7,8,9,10,11,12]. Basal-like breast cancers express many markers
associated with both myoepithelial and luminal epithelial cells
suggesting the bipotential differentiation pattern and possible stem
cell origin of these tumors [9,13,14]. Previous studies have
demonstrated increased expression of EMT markers at tumor-
stroma interfaces [15,16] and stromal cells are increasingly being
recognized as major players in cancer progression [17,18].
Increasing number of factors are known that can induce EMT
including transforming growth factor-b (TGF-b), ligands for
receptor tyrosine kinases such as vascular endothelial growth
factor (VEGF), epidermal growth factor (EGF) and hepatocyte
growth factor (HGF) as well as components of the extracellular
matrix [3,19]. These signaling events ultimately control transcrip-
tional regulatory factors such as Snail, Slug, Twist, ZEB1, ZEB2
and FOXC2 leading to increased and decreased expression of
mesenchymal and epithelial markers, respectively. Defining the
cellular and microenvironmental cues that trigger EMT during the
progression of breast cancers is critical and could provide new
therapeutic targets.
Vascular endothelial cells have attracted increased attention as
important regulators of organogenesis and stem cell maintenance
in various tissues, such as bone marrow, brain, liver and pancreas
[20,21,22,23]. Furthermore, intratumoral angiogenesis is also one
of the hallmarks of cancer progression and increased microvessel
density in tumors is an indicator of poor prognosis [12]. In the
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breast gland, Shekhar et al. have previously shown that human
umbilical vein endothelial cells (HUVEC) induce ductal-alveolar
morphogenesis of preneoplastic MCF10A cells [24]. We have
recently improved methods to propagate breast endothelial cells
(BRENCS) in culture and shown that BRENCS can mediate
proliferative and morphogenic signals to breast epithelial cells in
coculture [25,26]. In the lung, we have shown that endothelial
cells induce branching morphogenesis in lung epithelial cells when
cocultured in a 3D model. Interestingly, these structures mimic
phenotypic traits of lung histology in vivo including bronchio-
alveolar like structures [27]. Thus, data from diverse organs shows
that endothelial cells are important players in tissue remodeling
making this cell type particularly interesting as a regulator of
morphogenesis.
We have previously established a breast epithelial cell line,
referred to as D492, which has a basal-like phenotype as evidenced
by expression of both luminal (K8, K19) and myoepithelial (K5/6,
K14) cytokeratins. Furthermore, D492 has stem cell properties as
demonstrated by its ability to differentiate into luminal- and
myoepithelial cells and to form branching TDLU-like structures in
a 3D reconstituted basement membrane (rBM) [28,29]. Here, we
demonstrate in 3D coculture that endothelial cells are potent
inducers of EMT in D492 and this process is partially inhibited by
blocking HGF. Furthermore, we show in basal-like breast cancer
that N-Cad a marker of EMT is upregulated in proximity to
vascular rich areas. These data suggest that the vascular rich
stroma in breast cancer lesions might serve as an ideal niche for
the stimulation of epithelial cancer cells to undergo EMT, and
might especially apply to the highly aggressive basal-like breast
cancers, a subtype rich in stem cells.
Materials and Methods
Cell culture
D492 and D382 were cultured in H14 medium as described
previously [28]. W2320 cell line was cultured in DMEM/F12+5%
FBS [33]. The MCF-7, MCF10A and MDA-MB-231 cell lines
where purchased from ATCC (American Type Culture Collec-
tion) and are routinely authenticated with genotype profiling
according to ATCC guidelines. Primary human BRENCs were
isolated from breast reduction mammoplasties as previously
described by Sigurdsson et al. [25] and cultured on endothelial
growth medium (EGM) (Lonza) containing 50 IU/ml penicillin,
50 mg/ml streptomycin, hydrocortisone, FGF, EGF, VEGF, R3-
IGF-1, Ascorbic acid, Heparin, GA-1000 and supplemented with
5% FBS (EGM5). Growth factor reduced reconstituted basement
membrane (rBM, purchased as Matrigel, BD Biosciences) was
used in direct 3D coculture. Transwell coculture was conducted in
a 24 well setup with a 0,4 mm polyester membrane seperating the
chambers (Costar). 56104 endothelial cells were seeded in the
upper chamber as a monolayer and 250 D492 cells in 100 ml
matrigel on the bottom of the lower chamber maintained on
EGM5. For additional information on cell culture and 3D
coculture see Methods S1.
Blocking experiments
Direct coculture of 500 D492 cells with 26105 BRENCs in
300 ml of rBM were treated with 8 mg/ml anti-HGF neutralizing
antibody (#MAB294, R&D Systems) in the rBM and in the
medium. In transwell coculture HGF was blocked with 8 mg/ml
anti-HGF in the rBM and in the medium in the lower transwell
chamber and the controls were treated with mouse IgG1 in the
same manner.
Immunochemistry and tumor samples
Formalin-fixed, paraffin embedded tissue blocks were cut into
5 mm serial sections and mounted on slides. Sections were
deparaffinized and rehydrated in xylene and ethanol. Antigen
retrieval was done by boiling in citrate buffer for 15 min. The
following primary antibodies were used; fibronectin (LabMab, gift
from D.E. Mosher [30], CD-31 (M0823, DakoCytomation),
Keratin 19 (ab7754, Abcam), Keratin 14 (NCL-LL002, NovoCas-
tra), E-Cad (#13-1700, Zymed), N-Cad (#610920, BD), EpCAM
(NCL-ESA, Novocastra). For double and triple labelling experi-
ments we used fluorescence iso-type specific secondary antibodies
(Invitrogen). Fluorescent nuclear counterstain, TO-PRO-3 (Invitro-
gen) was used in immunofluorescence. Specimens were visualized
on a Zeiss LSM 5 Pascal laser-scanning microscope (Carl Zeiss).
Breast cancer specimens were from the clinical Department of
Pathology, Landspitali, University Hospital and included 9 basal-
like and four estrogen receptor positive (ER-positive) breast cancers.
This work has been approved by the National Bioethics Committee
of Iceland, Reference number VSNa2001050056.
Western blotting
Equal amounts (5 mg) of proteins were separated on 10%
NuPage Bis-Tris gels (Invitrogen) and transferred to a PVDF
membrane (Invitrogen). Antibodies: E-Cad (1:500; Zymed), N-
Cad (1:1000; BD), b-actin (1:5000; Abcam), GAPDH (1:5000;
Abcam), K5/6 (1:1000; Zymed), K8 (1:1000; Abcam), K14
(1:1000; Abcam), a-SM-Actin (1:500; Dako) K17 (1:500; Dako),
K19 (1:1000; abcam), Vimentin (1:1000;Dako) and FOXC2
(1:2000; Abcam) were used. Membranes were visualized with
ECL+ after incubation with anti-mouse or rabbit secondary
antibody (1:5000) (GE healthcare).
Migration, anchorage independence and mammosphere
assays
For migration experiments a total of 16104 and 2,56104
starved cells were seeded in DMEM/F12 basic medium on
collagen coated transwell filter in a transwell Boyden chamber
(Corning) with an 8 mm pore size. The transwell filter were
incubated in collagen (0.06 mg/ml) in PBS for 24 h at 4uC, then
excess collagen solution was rinsed off with PBS before cells were
seeded. EGM5 medium was used as a chemoattractant in the
lower chamber. After 12 h incubation cells in the upper chamber
were removed with a cotton swab and migrated cells on the
bottom surface stained with 0.1% crystal violet. Cells were counted
in three representative fields in each transwell. Soft agar assay was
performed by mixing 16104 D492 and D492M cells to 1.5 ml of
0.5% low melting agar (Invitrogen) that was overlaid on 1% agar
solution in 6 well plates and cultured on H14 medium. After 20
days the colonies were stained with crystal violet and counted.
Mammosphere assay was done in 24 well Ultra-Low attachment
plates (Corning) where 500, single cell filtered, D492 and D492M
cells were seeded and cultured on EGM5 medium. Number and
size of spheres was evaluated after 8 days.
Apoptosis resistance
D492 and D492M were seeded into 6 well culture plates (BD)
and grown to 70% confluency. Cells were treated with 10 mM of
Camptothecin (Sigma) in EGM5 medium and counted on culture
days 0–3.
Flow cytometry analysis
Adherent cells were trypsinized and filtered through a 30 nm
nylon filter (Millipore). Cells were incubated for 20 minutes with
Endothelial Induced EMT
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fluorochrome-conjugated antibodies against CD44 (clone IM7,
BD), CD24 (clone ML5, BD) or isotype-matched controls,
subsequently washed and resuspended in PBS with 4% formalde-
hyde (cell-fix). Cells were collected (26104 events) on a FACS-
Calibur (BD) and analysed using CellQuest (BD).
Statistical analysis
Data is presented as mean +SEM from number of independent
experiments as indicated. Statistical analysis was performed by
two-tailed Students T-test using GraphPad. P values of ,0.05
were considered to be statistically significant.
Results
Immortalized breast epithelial cell line with stem cell
properties generate mesenchymal-like cells in coculture
with endothelial cells
The D492 cell line forms branching structures in reconstituted
basement membrane (rBM) [28,29]. Growth of D492 alone in
rBM requires, however, moderate cell density (16104 cells per
300 ml rBM) [28]. In order to test the effects of breast endothelial
cells (BRENCs) on growth, and morphogenesis of D492 cells we
set up a coculture with BRENCS and D492 cells inside a rBM. In
this assay BRENCs remain viable and metabolically active but
non-proliferative (Fig S1). No growth was seen when D492 cells
were cultured alone at clonal dilution (500 cells per 300 ml rBM)
(Fig. 1A). In contrast, in coculture with BRENCs the total number
of D492 colonies increased with increasing amount of endothelial
cells reaching a cloning efficacy of 23.5% (117.363.5 colonies;
p,0.01) (Fig. 1A). In addition to solid round and branching
structures that have previously been shown to form when D492
are cultured alone, spindle shape, mesenchymal-like colonies
emerged in coculture with BRENCs (Figs. 1B and S2). No effect
was seen on endothelial cell morphology under coculture
conditions. These data suggest that BRENCs stimulate growth
and morphogenesis of D492 and furthermore induce the
formation of spindle-shaped colonies reminiscent of EMT in a
3D environment.
To see if the endothelial induced EMT-like phenotype was
breast-endothelial specific we also cocultured D492 with human
umbilical vein endothelial cells (HUVECs). HUVECs were also
able to induce a similar phenotype to what was seen in coculture
with BRENCs (data not shown) suggesting a general endothelial-
derived effect rather than an endothelial organ-specific effect.
As D492 has an immunophenotype similar to the cells of basal-
like breast cancer, we also tested W2320 which is a basal-like
metaplastic breast cancer cell line [31]. W2320 generated solid
epithelial colonies when cultured alone in 3D rBM. In contrast,
when cocultured with BRENCs there was a marked increase in
total colony formation and induction of spindle-like colonies
(Fig. 1C). We also tested several other cell lines in our 3D coculture
model. D382 is E6E7 immortalized cell line generated from
differentiated, normal, luminal breast epithelial cells [28] and
MCF10A is a non-tumorigenic epithelial cell line. MCF-7, is an
estrogen receptor positive breast cancer cell line, while MDA-MB-
231 is a highly malignant basal-like breast cancer cell line. When
these cell lines were cocultured with BRENCs in a rBM assay,
MDA-MB-231 generated mesenchymal colonies while D382 and
MCF10A, generated only round epithelial colonies (Fig. S3).
Furthermore, the estrogen receptor positive breast cancer cell line
Figure 1. Breast epithelial cells with stem cell properties generate spindle-like cells in coculture with endothelial cells. A, Colony
growth of D492-derived epithelial structures increases proportional with increased number of BRENCs in coculture. When 500 D492 cells are cultured
in 300 ml rBM they fail to grow (control). With BRENCs, colony growth increases from 76 (56104 BRENCs), 96 (16105 BRENCs) to 117 colonies (23,5%
cloning efficacy) when 26105 BRENCs are inoculated with 500 D492 cells. Average (AVG) number of colonies +SEM in three experiments. *, p,0.05;
**, p,0.01; compared to 56104 BRENCs. B, D492 generate spindle-like cells in coculture with BRENCs (26105 cells). D492 cells (500 cells incubated)
form three distinct structures, branching, solid, and spindle-like colonies. Appearance of the spindle colonies from D492 is novel and occurs only in
coculture with endothelial cells. Average % of colony type +SEM in three experiments. Bar 100 mm. C, Using a primary metaplastic breast cancer cell
line, W2320, we were able to show that these cells could also produce spindle-like colonies in coculture with BRENCs (right). Data shown as AVG
number of colonies +SEM in three experiments (left). *p,0.05. Bar 100 mm.
doi:10.1371/journal.pone.0023833.g001
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MCF-7, generated only large solid round colonies in coculture
with BRENCs (Fig. S3). This indicates that breast cancer cell lines
with basal-like characteristics have the plasticity for mesenchymal
conversion, in coculture with endothelial cells, while other more
differentiated cell lines are unable to undergo this transition.
Isolation and characterization of a D492-derived EMT cell
line
To analyze the origin and morphogenic capacity of branching
and spindle-like colonies from cocultures, we isolated single
colonies and plated them into monolayer culture. Cells derived
from branching colonies showed cuboidal epithelial phenotype
whereas cells from spindle-like colonies showed a spindle shaped
phenotype (Fig. 2). Spindle-like colonies were isolated and
expanded as sublines, one of them is referred to as D492M
(mesenchymal) (Fig. 2). When replated into secondary rBM
cocultures, cells from spindle-like colonies were fixed in making
similar colonies whereas cells from branching colonies retain the
ability to make both branching and spindle-like colonies (Fig. 2).
The parental cell line D492 was initially established by
transfection with a retroviral vector containing the E6 and E7
oncogenes and the neomycin resistant gene [28]. To eliminate
possible endothelial-derived contamination, the D492M subline
was selected in medium containing neomycin. Furthermore, we
cloned and sequenced an insertion site of the retrovirus (Methods
S1). We showed the presence of this insertion in D492M and four
different single cell-derived mesenchymal colonies as well as being
present in 5 different single cell derived D492 sub-clones (Fig.
S4A). To further confirm the epithelial origin of the mesenchymal
colonies we generated a D492 subline containing a GFP
expressing vector. When these GFP positive D492 cells were
cocultured with BRENCs all mesenchymal-like colonies were
green (Fig. S4B). This confirms the epithelial origin of the
mesenchymal colonies and furthermore confirms the clonal origin
of D492M from the D492 cell line.
Immunophenotypic characterization of D492M confirmed that
the spindle cell morphology was a direct consequence of EMT.
Thus, as opposed to the parent cell line, D492M has lost
expression of E-Cad and shows reduced expression of keratins 5/
6, 8, 14, 17, and 19, while showing increased expression of
Vimentin, N-Cad, and alpha-smooth muscle actin (Figs. 3A and
B). Using an Illumina BeadChip expression microarray (HumanWG-
6 v3.0) we screened the expression pattern in the two cell lines.
There was significantly different expression level of 9399 genes of
the 13105 genes that had detectable expression levels (for an FDR
of ,1%). Clustering pattern for the top 50 genes demonstrates the
clear differences between the two cell lines (Fig. S5). E-Cad,
keratins 5, 6, 14, and 19 were all downregulated in D492M
compared to D492. Likewise, mesenchymal markers such as N-
Cad, Thy-1, thrombin receptor (PAR1), and CD70 were all highly
up-regulated in D492M. Global gene expression shows EMT-
associated transcription factors that are upregulated in D492M,
including FOXC2 (3.96 fold), and FOXC1 (1.29 fold) (Fig. 3C).
FOXC2 upregulation in D492M was confirmed with western blot
and compared to D492, MDA-MB-231 and D382 (Fig. 3D). To
confirm that the EMT is causally driven by the endothelial-
induced EMT, rather than reflecting the properties of a single
clonal cell sub-line we isolated four other sublines from D492
Figure 2. Isolation of D492-derived mesenchymal-like cells (D492M). Six branching and six spindle-like colonies were isolated and plated in
monolayer culture. Cells from branching structures retain cuboidal epithelial phenotype in monolayer (left panel). When cocultured with BRENCs
these cells generate branching TDLU-like (40%) and spindle-like colonies (50%) in secondary 3D culture (u2 3D). Cells from spindle-like colonies (right
panel) showed mesenchymal/spindle like morphology in monolayer and cells isolated from one of these colonies gave rise to D492M. When
cocultured with BRENCs these cells only gave rise to spindle like colonies in secondary 3D coculture.
doi:10.1371/journal.pone.0023833.g002
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derived spindle-like colonies (D492M1-4). All these sublines were
shown to have acquired an EMT phenotype (Fig. S6).
D492M has acquired a functional EMT and cancer stem
cell phenotype
Amajor characteristic of the mesenchymal phenotype is increased
motility. In a transwell migration assay when compared to D492, the
D492M cells showed increased migration, 3.8 fold (p,0.05) and 7.4
fold (p,0.01) when plated at 16104 or 2.56104 cells, respectively
(Fig. 4A). Functionally, the D492M cells also showed signs of
transformation by growth in soft agar assay.While D492 fail to grow,
D492M grew well in this assay showing 6% cloning efficacy (p,0.01)
(Fig. 4B). In addition, when cultured in monolayer, D492M formed
multilayered ridges further indicating a loss of contact inhibition
(Fig. 4B, right). The CD44high, CD24low phenotype has been
associated with cancer stem cell phenotype in the breast [32] and
recently EMT-like traits have been added to this profile [6,7]. Flow
cytometry analysis showed that the D492 cells contain a mixture of
CD44high,CD24high cells (81%) and CD44high,CD24low cells (19%).
In contrast, D492M showed marked increase in the proportion of
CD44high, CD24low cells (70%) (Fig. 4C).
Papers have demonstrated a strong correlation between the
EMT phenotype and the ability to form mammospheres, an assay
that functionally tests for breast stem cell properties [6,33]. When
cultured in low attachment plates both D492 and D492M
generated mammospheres demonstrating the self-renewal and
cancer stem cell properties of these cell lines, respectively (Fig. 4D).
However, D492M generated significantly larger and higher
number of colonies (size.100 mm; p,0.01 and size.150 mm;
p,0.05) in this assay (Fig. 4D). One of the hallmarks of cancer
stem cells and EMT is the acquisition of apoptosis resistance
[6,34]. D492M showed increased resistance (p,0.05) to chemi-
cally induced apoptosis (Fig. 4E). Thus, D492M has acquired
phenotypic and functional characteristics of EMT cells and cancer
stem cells.
Endothelial induced EMT in D492 is generated through
soluble factors partially mediated by HGF
To analyze if endothelial induced EMT in D492 was mediated
through soluble factors we used transwell coculture with BRENCs
cultured on top of a filter and D492 cells embedded in rBM, in the
lower well (Fig. 5A). In this setup, BRENCs were even more
Figure 3. D492M has acquired an EMT phenotype. A, Immunofluoresence staining on D492M show switch from E- to N-Cad and reduced
expression of K14 and K19. Counterstain TO-PRO-3, Bar 100 mm. B, Western blotting confirms downregulation of epithelial markers such as E-Cad, K-
5/6, 8, 14, 17 and 19 in D492M. In contrast, the mesenchymal markers N-Cad, Vimentin and alpha-smooth muscle actin were expressed more
intensively in D492M than D492. GAPDH loading control. C, EMT associated transcription factors are upregulated in D492M. Gene expression data
showed upregulation of FOXC2 (3.96 fold,p: 8.4e-17) and FOXC1 (1.29 fold,p: 0.004) transcription factors in D492M. D, FOXC2 is strongly expressed in
breast epithelial cell lines with EMT phenotype. Western blotting shows strong expression of FOXC2 in D492M and MDA-MB-231, an EMT-like breast
cancer cell line, compared to no or low expression in D492 and D382. Actin, loading control.
doi:10.1371/journal.pone.0023833.g003
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effective in inducing the emergence of spindle-like colonies (Fig. 5B)
suggesting endothelial-derived soluble factor/s. These spindle-like
colonies show an EMT phenotype with an E- to N-Cad switch,
reduced K14 and K19 expression and increased expression of
vimentin and fibronectin (Fig. 5C). It should, however, be noted
that in this setup a few small colonies grew in D492 monoculture
and were either of solid round or spindle-like morphology. The
reason for this is unknown but may be due to the difference in the
experimental setup of the transwell compared to the direct
coculture 3D experiments.
Figure 4. D492M has acquired cancer stem cell-like phenotype. A, D492M show increased migration compared to D492. Increased migration
was seen at the two cell concentrations (16104 and 2.56104). B, D492M grow anchorage independently. In 0.5% soft agar D492 cells fail to form
colonies. In contrast, the D492M cells are able to grow, indicating acquisition of anchorage independent growth. In monolayer culture (right) D492
cells are contact inhibited while D492M piles up in the culture flask indicating lack of contact inhibition (arrows). Counterstain hematoxylin. Bar
100 mm. C, D492M cells are CD44high,CD24low consisting with the breast cancer stem cell phenotype. D492 contain a subpopulation (19%) of cells
that are CD44high, CD24low. This population increases to 70% in the D492M cell line. D, D492 and D492M differ in their ability to form mammospheres.
Both D492 and D492M can generate colonies in mammosphere assay, however, D492M generates more and larger (.100 mm: 1.7 fold; .150 mm:1.5
fold) mammospheres than D492 cells. E, D492M cells show delayed chemically induced apoptosis. D492 and D492M show distinct responses to
Camptothecin, an apoptosis inducing agent. D492 cells underwent immediate apoptosis and showed cell survival under 40% on day 2 while having
no effect on D492M. On day 3 D492M cells showed cell survival of 60% where only few D492 cells were left. Data shown as AVG number of cells per
field (A,E) or AVG number of colonies (B,D) +SEM in three experiments. *p,0.05; **p,0.01.
doi:10.1371/journal.pone.0023833.g004
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There are a number of factors that can elicit EMT such as
TGF-b1, FGF, EGF and HGF. As D492 did not form any EMT
in the EGM5 coculture media that contains EGF, FGF and VEGF
we set focused on TGF-b1 and HGF, known morphogenic and
EMT inducing factors [3]. We treated 3D cocultures with a small
molecule inhibitor targeting the TGF-b receptor-1 (ALK5) and
with a TGF-b1 neutralizing antibody. We observed no changes in
the number of spindle colonies using the ALK5 kinase inhibitor or
the anti-TGF-b1 (not shown) indicating that other factors were
responsible for the endothelial induced EMT.
HGF is expressed in endothelial cells and other stromal cells
and can induce both scattering (including EMT) and morpho-
genic effects on epithelial cells [35]. In our 3D rBM assay
BRENCs secreted HGF into the surrounding culture media as
Figure 5. Endothelial induced EMT is mediated through soluble factors and is partially blocked by inhibition of HGF. A, In the
transwell coculture setup endothelial cells were cultured as a monolayer in the upper well and D492 cells in 3D rBM on the bottom of the lower well.
B, BRENCs induce spindle-like colony formation in transwell coculture. D492 cells without BRENCs showed limited growth (less than 1% of seeded
cells, control). coculture the BRENCs induced a significant increase in number of spindle-like colonies. C, D492-derived branching colonies generated
in transwell culture show characteristical epithelial phenotype including expression of E-Cad, K14 and K19. In contrast, D492-derived spindle like
colonies show EMT phenotype including expression of N-Cad, Vimentin and fibronectin (FN). Bar 100 mm. D–E, Formation of spindle-like colonies is
partially blocked by inhibition of HGF. Spindle-like colony formation is reduced with anti-HGF by 44% in direct coculture (D) and by 30% in transwell
coculture (E). Data shown as AVG number of colonies +SEM in three experiments. *p,0.05; **p,0.01.
doi:10.1371/journal.pone.0023833.g005
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measured by ELISA. They secreted over four times higher
concentrations than D492 in this setup (Fig. S7). When coculture
of D492 and BRENCS was treated with a neutralizing antibody
against HGF a significant decrease (p,0.01) in spindle colonies was
observed in contrast to a significant increase (p,0.01) in the
formation of branching colonies (Fig. 5D). We also tested this in
transwell coculture and as before BRENCs induced the emergence
of spindle colonies. Neutralizing antibody against HGF significantly
decreased (p,0.05) their number but had no effects on branching
colonies (Fig. 5E). Collectively, this suggests that the balance in
formation of branching or spindle colonies from D492 cells can be
modulated by HGF signaling and that soluble HGF, at least
partially, mediates endothelial induced EMT in our 3D coculture
model.
EMT phenotype in basal-like breast cancers is associated
with vascular-rich areas
Circumstantial evidence suggests that basal-like breast cancers
originate in epithelial stem or progenitor cells [14]. Furthermore,
studies show that these tumors are highly vascularized [36,37] and
rich in EMT associated markers such as N-Cad with low or no E-
Cad expression [9,11]. Because both EMT and angiogenesis are
associated with increased metastatic potential, we explored the
possible connection between vascularization and the EMT
phenotype within basal-like breast cancer. We stained 9 basal-
like and four estrogen receptor positive (ER-positive) breast
cancers with antibodies against E-Cad, N-Cad, K14, K19 and
CD-31. While all ER-positive cancers were N-Cad and K14
negative, basal-like cancers were positive for N-Cad and K14, with
some tumors showing medium-to-low expression of N-Cad
(Fig. 6A). To study the possible association between vasculariza-
tion and the EMT-phenotype, we quantified the microvascular
density (MVD) in N-Cad medium-to-low areas and in N-Cad high
areas. Microvessel density (MVD) was significantly higher in areas
containing cells with high expression of N-Cad (MVD:
86.7763.52) compared to areas with low N-Cad expression
(MVD: 36.6664.01) (Fig. 6B, 6C and Fig. S8). Low or no
expression of E-Cad was seen in all basal-like biopsies tested
(Fig. 6D). Thus the cellular context in basal like breast cancers
reveals an interesting pattern of cancer cells showing an EMT
phenotype closely associated with vascular rich components. Based
on these findings we hypothesize that the endothelial compartment
might contribute to the EMT phenotype of tumor cells within
basal like breast cancer.
Discussion
We report here, that in a 3D coculture model EMT-like cells
arise from immortalized breast epithelial cells with stem cell
properties upon interaction with breast endothelial cells. These
effects are at least partially mediated through HGF with other
endothelial-derived factors possibly involved. The endothelial
induced transition resulted in a characteristic EMT phenotype as
evidenced by marked difference in protein and gene expression
with loss of many adhesion and epithelial specific markers and
gain of mesenchymal markers. Functionally, the EMT cells
showed increased migratory abilities and an increase in cancer
stem cell phenotype. Furthermore, we show that basal-like breast
cancers are rich in cells showing a potential EMT phenotype
with highest intensity of N-Cad expression close to vascular rich
areas.
EMT has recently been linked to basal-like breast cancer as
demonstrated by upregulation of EMT markers (Vimentin, alpha-
smooth muscle actin, and N-Cad) together with reduction of
characteristic epithelial markers (E-Cad and keratins) [9,11]. This
is supported by our observation that basal like breast cancers have
features of EMT as evidenced by no or reduced expression of E-
Cad and high expression of N-Cad. Interestingly, the strongest
expression of N-Cad was seen in vascular-rich areas suggesting
that endothelial cells may provide a favorable environment for the
EMT phenotype. Intratumoral angiogenesis, assessed by micro-
vessel density, has been proposed to identify patients at high risk of
recurrence, especially in node-negative breast cancer. Meta-
analyses have confirmed this association, although being a
relatively weak risk factor [38]. More recent studies have shown
that microvessel density might be a major risk factor in triple
negative breast cancer [39] and vascular endothelial growth factor
(VEGF), a marker of angiogenesis, has also been shown to be
significantly higher in this subclass of breast cancer [40]. High
MVD has also been associated with medullary breast tumors,
which are a subtype of the basal-like group and with breast tumors
with a predominant CD44high/CD24low cancer stem cell pheno-
type [37,41]. Niu et al. have also showed in hepatocellular
carcinoma, that tumors expressing Twist, a marker of EMT, have
higher MVD [42].
EMT is a complex process and there have been numerous
factors shown to elicit EMT in culture. Of these, TGF-b1 and
ligands for various receptor tyrosine kinases have received much
attention [34]. We report here that inhibition of TGF-b1 with a
neutralizing antibody or an ALK5 inhibitor did not affect the
formation of spindle-like colonies in coculture suggesting that
TGF-b1 is not involved in endothelial induced EMT in the 3D-
context. Interestingly, Mostov et al. reported that HGF induces
partial EMT in MDCK cells cultured in 3D collagen gel [35].
The HGF receptor, c-Met has also been shown to have a higher
expression in basal-like breast cancer than in other subtypes.
Basal-like breast cancer are also enriched for gene sets indicating
transcriptional activation induced by c-Met signaling [43].
Hypoxia, a major effector of endothelial cells has been shown
to increase HGF mRNA stability through overexpression of HIF-
1alpha [44]. Hypoxia has also been shown to increase the
expression of c-Met, leading to increased sensitivity to HGF and
an invasive phenotype in the tumor cells [45]. In our study,
endothelial cells were shown to secrete HGF in 3D culture and
when HGF was blocked with a neutralizing antibody in direct-
and indirect (transwell) coculture a significant reduction in the
number of EMT colonies was observed demonstrating that
endothelial-derived HGF is, at least partially, responsible for
EMT in our culture model. These findings suggest a novel role
for endothelial cells and angiogenesis in cancer progression in
addition to the more classical role of oxygen and nutritional
delivery.
Defining the cellular and microenvironmental cues that trigger
EMT during cancer progression is important. Studies have shown
increased expression of EMT markers at the tumor-stroma
interface [15,16] and stromal cells are now recognized as major
players in cancer progression (reviewed in [17,18]). The stromal
compartment includes various cell types, e.g. fibroblasts (and
myofibroblasts), immune cells and endothelial cells. Fibroblasts
and myofibroblasts have received attention as important players in
tissue morphogenesis and neoplasia [17,46]. We have previously
shown that breast cancer cells can generate non-malignant
fibroblast-like cells that can facilitate growth and invasion of
cancer cells [31]. Myofibroblast have been shown to induce EMT
and tumor progression in a hepatocellular carcinoma mouse
model through PDGF and TGF-beta signaling [47]. Recently,
CD8 positive T cells have been shown to induce EMT in mouse
mammary cancer cells. Following T cell-induced EMT, these
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Figure 6. The EMT phenotype is most prominent close to vascular rich areas in basal-like breast cancer. A, N-Cad expression is most
prominently found within basal-like breast cancer. ER tumors are K19 positive but negative for N-Cad and K14. In contrast basal-like breast cancers
(BLBC) are positive for all three markers. Bar 100 mm. B, Increased microvessel density in basal-like breast cancer is associated with areas containing
cells with high expression of N-Cad. Immunostaining show increased CD31 positive microvessels in areas with high N-Cad expression. Statistcal
analyzis (bottom) from three basal-like breast cancer biopsies show significant increase in microvessels within areas with high N-Cad expression. C,
Expression of CD-31 reveals highly vascularized area at the tumor stroma interface. N-Cad expression was seen in most cancer cells. Note the strong
expression of N-Cad close to the vascular rich area (dashed line). D, Double-labeling against E- (red) and N-Cad (green) in the same area shows strong
expression of N-Cad only. Low or no expression of E-Cad (red) was seen close to the CD31 positive (green) endothelial cells. Cells were counterstained
with hematoxylin (A B and C) and TO-PRO-3 (D). Bar, 100 mm.
doi:10.1371/journal.pone.0023833.g006
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cancer cells acquired cancer stem cell phenotype including
increased CD44high/CD24low ratio, drug resistance and increased
tumorigenicity [48].
Although EMT can easily be recognized in monolayer culture
of cells, recognizing these cells in situ is more troublesome, due to
its transient nature. In contrast to monolayer cultures, 3D
culture models capture more closely the in vivo situation [49].
Papers from our laboratory and others have shown the
importance of 3D cultures to elucidate the functional role of
the stroma as an instructive factor in normal breast morpho-
genesis and cancer progression [17,18,49,50,51]. Numerous cell
lines, such as MCF10A and MCF-7, have been reported to be
susceptible to EMT in traditional monolayer culture [52]. Our
results, however, show that in 3D culture EMT induction by
BRENCs is only achieved in selected cell lines, i.e. those
harboring stem/progenitor characteristics (D492) and/or cell
lines that have cancer initiating abilities (MDA-MB 231). We
also show that primary metaplastic breast cancer cells, W2330
[31], can be facilitated to undergo EMT in 3D coculture with
BRENCs. In contrast the luminal epithelial cell line D382,
MCF10A and MCF-7 show no signs of EMT in coculture with
BRENCs. Even though MCF10A has been shown to have a
basal-like phenotype, they lack fundamental stem cell properties
that D492 has, such as branching morphogenesis that may
explain why they are non-responsive to endothelial induced
EMT in 3D cultures.
Recent studies have shown that induction of EMT in
immortalized human breast epithelial cells was associated with
acquisition of cancer stem cell associated properties, measured by
increased expression of CD44high/CD24low cells accompanied by
the ability to form mammosphere colonies in culture [6,7]. In
these studies, immortalized breast epithelial cells (HMECs) were
induced to undergo EMT in 2D culture conditions with TGF-b1
or transfected with potent inducers of EMT such as snail, Twist
or the ras oncogene. These studies are in line with our data where
D492M show cancer stem cell and tumorigenic phenotype as
evidenced by an increased ratio of CD44high/CD24low cells,
ability to form mammospheres, increased motility, anchorage
independent growth and resistance against chemically induced
apoptosis. It is noteworthy that in our study, D492, a cell line
with epithelial stem cell properties, appear to lose the normal
epithelial stem cell properties (i.e. generating differentiated
luminal and myoepithelial cells and forming branching TDLU-
like structures) after undergoing EMT and acquire a phenotype
associated with cancer stem cells. This suggests an important
difference between the properties of breast epithelial stem cells
and epithelial cancer stem cells. Studies linking cancer stem cells
and EMT also raise interesting questions about the cell renewal,
developmental plasticity and signaling pathways involved in
cancer progression.
In this paper we show that in basal like breast cancer, cells
undergoing EMT are enriched in the vascular-rich areas and
furthermore, we show that endothelial cells can directly induce
EMT. This endothelial-induced EMT is at least partially
facilitated by HGF making this a potential novel therapeutic
target for patients with the basal-like subtype of breast cancer.
Furthermore, our findings suggest a role for endothelial cells in
basal-like breast cancer suggesting that therapy targeting the
neovascular compartment might be relevant.
Supporting Information
Figure S1 Endothelial cells cultured in rBM appear as
single, non proliferative but metabolically active cells.
Endothelial cells cultured for 10 days within rBM remain as single
non proliferative but metabolically active as seen by the uptake of
fluorescent labeled Ac-LDL (green). Insert shows single endothelial
cells that have taken up Ac-LDL in higher magnification.
(TIF)
Figure S2 Spindle-like colony formation increases pro-
portionally with the amount of endothelial cells. Increased
number of BRENCs in coculture with D492 results in decreased
and increased number of solid and spindle-like colonies. No effect
was seen on branching colonies. AVG % of colonies +SEM in
triplicate. *, p,0.05; **, p,0.01; compared to 56104 BRENCs.
(TIF)
Figure S3 BRENCs facilitate mesenchymal phenotype
in MDA-MB-231 a poorly differentiated breast cancer
cell line. To explore if BRENC could induce EMT in other cell
types we set up cocultures of BRENCs (26105 cells) with
MCF10A, MCF-7, D382 and MDA-MB-231 (500 cells). Cocul-
ture of BRENCs with MCF-10A, D382 and MCF-7 resulted in
non-branching, non-EMT-like epithelial colonies. In contrast
coculture of BRENCs with the highly malignant cancer cell line
MDA-MB-231 resulted in large EMT-like colonies. Bar 100 mm.
(TIF)
Figure S4 D492 and D492M share a common origin. A,
Origin of D492M confirmed by viral insertional analysis. D492
cell line contains a retroviral insertion of E6 and E7 genes. The
insert site was identified (schematic) on chromosome 20q13.1 close
to the gene PTP1N that codes for the protein tyrosine phosphatese
1B (PTP1B). PCR analyzes identified the same insert in D492M
confirming its origin from D492. B, GFP positive D492 cells give
rise to mesenchymal colonies in coculture with BRENCs. The
origin of mesenchymal colonies from D492 was confirmed by
using GFP positive D492. All colonies in the 3D culture were GFP
positive. Bar = 100 mm.
(TIF)
Figure S5 Gene expression analysis demonstrates glob-
al changes in D492-D492M transition. Heat map showing
the top 50 genes discriminating D492 and D492M. Red and green
shows up- and down regulation of genes, respectively.
(TIF)
Figure S6 Characterization of four mesenchymal-de-
rived cell lines from D492. D492-derived mesenchymal cell
lines designed D492M1-M4 were characterized in terms of
expression profile and for functional mesenchhymal properties.
A. D492M1 show reduced expression of E-cadherin and EpCAM,
weak expression of N-Cad and strong expression of fibronectin
(FN) and vimentin. B. D492M-1 show increased migration
compared to D492. C. Mesenchymal cell lines derived from
D492 show advanced growth in soft agar. D. Summary of
phenotypic and functional characteristics of D492M1-M4.
(TIF)
Figure S7 BRENCs secreted HGF into the surrounding
culture media. BRENCs secreted HGF into the surrounding
culture media as measured by ELISA. BRENCs secreted over four
times higher concentration of HGF than D492 when cultured
rBM.
(TIF)
Figure S8 N-cadherin expression is prominent around
vascular rich area of basal-like breast cancers. Two basal
like breast cancer were stained with antibodies against N-Cad and
CD31. Figures show N-Cad high and N-Cad medium/low areas
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within the same cancer stained with N-Cad and CD31. Cells
counterstained with heamotoxylin. Bar = 100 mm.
(TIF)
Methods S1 Supplementary material and methods.
(DOC)
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